Patient safety is a paramount concern in cancer clinical trials. A CTMS enhances patient safety by ensuring rigorous adverse event reporting and monitoring. It helps in real-time tracking of patient health data, which enables quick responses to any adverse reactions. Furthermore, it ensures that all trial protocols are strictly followed, reducing the risk of errors.
